NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.67 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.67 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 101 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
% | $1.86 Billion | Healthcare | Biotechnology | $21.49 | +2.92% |
| 102 |
Tyra Biosciences Inc
NASDAQ:TYRA |
% | $1.83 Billion | Healthcare | Biotechnology | $34.04 | -2.04% |
| 103 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
% | $1.83 Billion | Healthcare | Biotechnology | $31.83 | +1.82% |
| 104 |
Stoke Therapeutics Inc
NASDAQ:STOK |
% | $1.82 Billion | Healthcare | Biotechnology | $33.08 | +1.10% |
| 105 |
Mesoblast Ltd
NASDAQ:MESO |
% | $1.82 Billion | Healthcare | Biotechnology | $15.74 | +0.45% |
| 106 |
Relay Therapeutics Inc
NASDAQ:RLAY |
% | $1.81 Billion | Healthcare | Biotechnology | $12.72 | -1.85% |
| 107 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
% | $1.80 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $80.39 | +1.18% |
| 108 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
% | $1.79 Billion | Healthcare | Biotechnology | $26.61 | -3.38% |
| 109 |
GRAIL, LLC
NASDAQ:GRAL |
% | $1.79 Billion | Healthcare | Diagnostics & Research | $54.06 | -0.77% |
| 110 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
% | $1.78 Billion | Healthcare | Biotechnology | $41.70 | +1.14% |
| 111 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
% | $1.77 Billion | Healthcare | Biotechnology | $16.01 | +0.06% |
| 112 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
% | $1.76 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $15.50 | +0.00% |
| 113 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
% | $1.74 Billion | Healthcare | Biotechnology | $3.39 | -2.02% |
| 114 |
Tango Therapeutics Inc
NASDAQ:TNGX |
% | $1.74 Billion | Healthcare | Biotechnology | $20.98 | -2.96% |
| 115 |
Vericel Corp Ord
NASDAQ:VCEL |
% | $1.73 Billion | Healthcare | Biotechnology | $35.57 | +2.42% |
| 116 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
% | $1.70 Billion | Healthcare | Biotechnology | $16.81 | +0.66% |
| 117 |
Ardelyx Inc
NASDAQ:ARDX |
% | $1.67 Billion | Healthcare | Biotechnology | $6.88 | +8.69% |
| 118 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
% | $1.66 Billion | Healthcare | Biotechnology | $19.11 | -10.83% |
| 119 |
Innoviva Inc
NASDAQ:INVA |
% | $1.66 Billion | Healthcare | Biotechnology | $23.11 | +0.52% |
| 120 |
Agios Pharm
NASDAQ:AGIO |
% | $1.62 Billion | Healthcare | Biotechnology | $28.16 | +0.57% |
| 121 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
% | $1.61 Billion | Healthcare | Biotechnology | $33.89 | +2.29% |
| 122 |
Vir Biotechnology Inc
NASDAQ:VIR |
% | $1.57 Billion | Healthcare | Biotechnology | $10.00 | -2.10% |
| 123 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
% | $1.57 Billion | Healthcare | Biotechnology | $13.26 | -1.63% |
| 124 |
Harrow Health Inc
NASDAQ:HROW |
% | $1.51 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $40.90 | +0.91% |
| 125 |
Precigen Inc
NASDAQ:PGEN |
% | $1.44 Billion | Healthcare | Biotechnology | $4.08 | -1.92% |
| 126 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
% | $1.42 Billion | Healthcare | Biotechnology | $13.87 | +0.80% |
| 127 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
% | $1.42 Billion | Healthcare | Biotechnology | $28.16 | +0.90% |
| 128 |
Wave Life Sciences Ltd
NASDAQ:WVE |
% | $1.34 Billion | Healthcare | Biotechnology | $7.32 | +3.68% |
| 129 |
Novavax Inc
NASDAQ:NVAX |
% | $1.31 Billion | Healthcare | Biotechnology | $8.04 | +1.45% |
| 130 |
Novocure Ltd
NASDAQ:NVCR |
% | $1.28 Billion | Healthcare | Medical Devices | $16.62 | +9.27% |
| 131 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
% | $1.25 Billion | Healthcare | Biotechnology | $15.46 | +1.78% |
| 132 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
% | $1.25 Billion | Healthcare | Biotechnology | $6.33 | -0.94% |
| 133 |
Tourmaline Bio Inc.
NASDAQ:TRML |
% | $1.23 Billion | Healthcare | Biotechnology | $47.98 | +0.00% |
| 134 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
% | $1.22 Billion | Healthcare | Biotechnology | $18.80 | -1.83% |
| 135 |
Uniqure NV
NASDAQ:QURE |
% | $1.19 Billion | Healthcare | Biotechnology | $19.13 | -4.11% |
| 136 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
% | $1.15 Billion | Healthcare | Biotechnology | $14.32 | -0.62% |
| 137 |
Phibro Animal Health Corporation
NASDAQ:PAHC |
% | $1.13 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $54.89 | +3.22% |
| 138 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
% | $1.13 Billion | Healthcare | Biotechnology | $21.53 | +0.00% |
| 139 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
% | $1.10 Billion | Healthcare | Biotechnology | $13.34 | +1.06% |
| 140 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
% | $1.09 Billion | Healthcare | Biotechnology | $9.77 | -1.11% |
| 141 |
Collegium Pharmaceutical Inc
NASDAQ:COLL |
% | $1.08 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $34.32 | +1.75% |
| 142 |
Abcellera Biologics Inc
NASDAQ:ABCL |
% | $1.07 Billion | Healthcare | Biotechnology | $4.43 | +6.75% |
| 143 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
% | $1.05 Billion | Healthcare | Biotechnology | $128.79 | -0.33% |
| 144 |
Savara Inc
NASDAQ:SVRA |
% | $1.04 Billion | Healthcare | Biotechnology | $5.12 | -2.29% |
| 145 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
% | $1.04 Billion | Healthcare | Biotechnology | $6.28 | +2.53% |
| 146 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
% | $1.03 Billion | Healthcare | Biotechnology | $3.40 | +1.19% |
| 147 |
Geron Corporation
NASDAQ:GERN |
% | $1.01 Billion | Healthcare | Biotechnology | $1.58 | +2.60% |
| 148 |
UroGen Pharma Ltd
NASDAQ:URGN |
% | $999.45 Million | Healthcare | Biotechnology | $23.00 | -3.48% |
| 149 |
Verve Therapeutics Inc
NASDAQ:VERV |
% | $994.04 Million | Healthcare | Biotechnology | $11.13 | +0.00% |
| 150 |
Pacira BioSciences, Inc.
NASDAQ:PCRX |
% | $989.57 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $24.44 | -4.12% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices